The estimated Net Worth of Giuseppe Papandrea is at least $2.15 Million dollars as of 14 April 2021. Mr. Papandrea owns over 24,759 units of Zynex Inc stock worth over $250,692 and over the last 5 years he sold ZYXI stock worth over $0. In addition, he makes $1,901,890 as Chief Operating Officer at Zynex Inc.
Giuseppe has made over 1 trades of the Zynex Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 24,759 units of ZYXI stock worth $197,082 on 14 April 2021.
The largest trade he's ever made was exercising 24,759 units of Zynex Inc stock on 14 April 2021 worth over $197,082. On average, Giuseppe trades about 2,251 units every 0 days since 2019. As of 14 April 2021 he still owns at least 31,494 units of Zynex Inc stock.
You can see the complete history of Mr. Papandrea stock trades at the bottom of the page.
Giuseppe Papandrea serves as Chief Operating Officer of the Company. Previously serving as Vice President Operations for Arrow Electronics (Nasdaq: ARW), the world’s largest distributor of electronic components and enterprise computing solutions, from December 2016 through June 2019. Mr. Papandrea utilized his global background, breadth of organizational functional knowledge, and analogous vertical experience to help customers in Security, Healthcare and Medical, Technology and Media scale rapidly to meet emerging and demanding end market technology requirements. Prior to joining Arrow Electronics Mr. Papandrea worked for Orica Inc. (ASX: ORI) from January 2012 through June 2016 in various locations around the world including Australia, Singapore, Germany, the UK, Chile and the USA in a variety of senior leadership roles. Initiating and driving M&A, integration, scale, and transformation across disparate geographic markets and industries including; Resources/Industrial, Energy, Technology, Transportation, and Retail. Mr. Papandrea is a CPA, who holds a Bachelor of Commerce, (minor in Accounting and Law) from the University of Western Sydney in Australia, and has earned corporate sponsorship to undertake executive leadership development programs through institutions such as INSEAD, the Mt. Eliza Business School, ENS International, and Korn Ferry, in addition, he is an active member and supporter of the Colorado Special Olympics movement.
As the Chief Operating Officer of Zynex Inc, the total compensation of Giuseppe Papandrea at Zynex Inc is $1,901,890. There are no executives at Zynex Inc getting paid more.
Giuseppe Papandrea is 47, he's been the Chief Operating Officer of Zynex Inc since 2019. There are 5 older and 2 younger executives at Zynex Inc. The oldest executive at Zynex Inc is Barry Michaels, 70, who is the Independent Director.
Giuseppe's mailing address filed with the SEC is C/O ZYNEX, INC., 9555 MAROON CIRCLE, ENGLEWOOD, CO, 80112.
Over the last 6 years, insiders at Zynex Inc have traded over $45,302,249 worth of Zynex Inc stock and bought 14,733 units worth $121,235 . The most active insiders traders include Thomas Sandgaard Holdings L..., Joshua R. Disbrow und Thomas Sandgaard. On average, Zynex Inc executives and independent directors trade stock every 56 days with the average trade being worth of $657,783. The most recent stock trade was executed by Anna Lucsok on 6 August 2024, trading 24,875 units of ZYXI stock currently worth $199,498.
zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.
Zynex Inc executives and other stock owners filed with the SEC include: